So far, several serum and plasma tumour markers have been identified and associated with different cancer types to monitor the cancer status and the response to therapies, including prostate-specific antigen for prostate cancer, CA 125 for ovarian cancer, and CA 19-9 for pancreatic cancer [10]. The gene discussed is KLK3; the disease is cancer.